Vanguard Group Inc. increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,446,437 shares of the biotechnology company's stock after purchasing an additional 275,959 shares during the period. Vanguard Group Inc. owned approximately 11.08% of Axon Enterprise worth $5,019,886,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Prestige Wealth Management Group LLC grew its position in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the 4th quarter worth approximately $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter valued at approximately $41,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise in the fourth quarter worth $53,000. Institutional investors own 79.08% of the company's stock.
Insider Activity at Axon Enterprise
In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of research firms recently commented on AXON. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC reissued a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $604.67.
View Our Latest Report on Axon Enterprise
Axon Enterprise Stock Up 0.8 %
NASDAQ:AXON traded up $4.66 on Tuesday, hitting $577.18. 439,520 shares of the company's stock were exchanged, compared to its average volume of 835,219. The firm has a 50-day moving average price of $591.92 and a 200-day moving average price of $546.67. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $44.23 billion, a P/E ratio of 149.14, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.